Michael Severino, AbbVie president and soon-to-be Flagship Pioneering CEO-partner

April 13, 2022 10:43 AM EDT

AbbVie president Michael Severino heads to Flagship as biotech incubator's third CEO-partner in six days

Kyle LaHucik

Senior Reporter

AbbVie president and vice chair Michael Severino is leaving the Chicago-area pharma giant on May 31 to become a CEO-partner at prolific biotech creator Flagship …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

AbbVie president Michael Severino heads to Flagship as biotech incubator's third CEO-partner in six days

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

In surprise, study suggests Covid mRNA vaccines may boost cancer immunotherapy efficacy

Pfizer tees up Phase 3 test in weight management — but in an unexpected area

Ex-Kite leaders step in at Kyverna as CEO exits after landing year's second-biggest IPO

BioNTech rolls out Phase 2 lung cancer data as VEGF bispecifics take center stage

Immatics loses Bristol Myers' support on Phase 1 bispecific T cell engager

Breaking down silos with a new quantitative approach to drug development

Ab­b­Vie pres­i­dent Michael Sev­eri­no heads to Flag­ship as biotech in­cu­ba­tor's third CEO-part­ner in six days

Senior Reporter

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

AbbVie president Michael Severino heads to Flagship as biotech incubator's third CEO-partner in six days